Mar 21, 2025 06:00AM
Mar 5, 2025 07:02AM
Mar 5, 2025 07:00AM
Feb 18, 2025 07:03AM
Feb 18, 2025 07:00AM
Jan 13, 2025 07:00AM
Jan 6, 2025 10:35AM TD Cowen: '10 Potential "Thome Run" Catalysts to Watch in 2025'
Dec 31, 2024 06:33AM
Dec 30, 2024 07:02AM
Dec 30, 2024 07:00AM
Dec 9, 2024 04:02PM
Dec 9, 2024 04:01PM
Dec 8, 2022 05:00PM
Nov 3, 2022 07:00AM Chimerix Reports Third Quarter 2022 Financial Results and Provides Operational Update
Sep 26, 2022 04:05PM
Aug 29, 2022 10:47AM
Aug 29, 2022 10:45AM
Aug 8, 2022 04:01PM
Aug 8, 2022 07:00AM
Jun 24, 2022 10:07AM
Jun 24, 2022 10:06AM Chimerix Announces TEMBEXA Procurement Agreement for Approximately $25.3 Million with Public Health Agency of Canada
Jun 23, 2022 09:16AM
Jun 23, 2022 09:15AM
May 16, 2022 09:25AM
May 16, 2022 07:00AM
May 16, 2022 06:33AM
May 16, 2022 06:32AM
May 16, 2022 06:32AM Emergent BioSolutions to Acquire from Chimerix its Exclusive Worldwide Rights to TEMBEXA® (brincidofovir), the First FDA-Approved Smallpox Oral Antiviral for All Ages
May 16, 2022 06:30AM
May 9, 2022 07:00AM
Mar 21, 2022 07:00AM
Mar 1, 2022 07:00AM
Feb 28, 2022 07:00AM
Feb 24, 2022 07:00AM
Jan 20, 2022 08:00AM Chimerix to Present at B. Riley Virtual Oncology Conference
Jan 18, 2022 04:02PM
Jan 18, 2022 04:01PM
Jan 3, 2022 04:45PM
Nov 19, 2021 07:02AM
Nov 19, 2021 07:00AM
Nov 12, 2021 08:00AM
Nov 11, 2021 07:00AM Chimerix Announces Upcoming Presentations at the Society for Neuro-Oncology Annual Meeting 2021
Nov 4, 2021 07:05AM
Nov 4, 2021 07:04AM
Nov 4, 2021 07:00AM
Nov 1, 2021 08:00AM
Oct 28, 2021 07:00AM
Sep 7, 2021 07:00AM
Aug 5, 2021 07:00AM Chimerix Reports Second Quarter 2021 Financial Results and Provides Operational Update
Aug 3, 2021 07:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All